LN Robotics develops AVIAR, Korea's first vascular interventional robot designed to assist in percutaneous coronary interventions while significantly reducing radiation exposure for both clinicians and patients. By integrating clinical expertise and big data from leading hospitals, the company enhances the precision and safety of cardiovascular procedures.
Funding
Funding not disclosed
Founders
Product
Problem
During percutaneous coronary interventions (PCIs), clinicians are exposed to significant radiation, posing health risks despite protective measures. Traditional PCI procedures also demand a high degree of precision and can be physically taxing for the interventional cardiologist.
Solution
LN Robotics has developed AVIAR, a vascular interventional robot designed to assist clinicians during PCI procedures, significantly reducing their radiation exposure. AVIAR enhances the precision and safety of cardiovascular procedures through its robotic arm and control system. The system integrates clinical expertise and procedural data from leading hospitals to optimize workflow and improve patient outcomes. By automating key steps and providing enhanced visualization, AVIAR aims to improve the efficiency and consistency of PCI procedures.
Target Audience
The primary target audience includes interventional cardiologists, hospitals, and cardiac catheterization labs seeking to reduce radiation exposure, improve procedural precision, and enhance the efficiency of PCI procedures.
Features
- Robotic arm with precise and controlled movements for guiding interventional tools
- Real-time imaging integration for enhanced visualization of the vasculature
- Remote control system allowing clinicians to operate from a shielded environment, minimizing radiation exposure
- Integration of clinical data and best practices to optimize procedural steps
- Force feedback mechanisms for tactile control and enhanced precision
- Compatibility with standard PCI equipment and workflows